Larry Dillaha News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Melt Pharmaceuticals raises $24M in Series B

Company to begin human trials on opioid- and needle-free sedation drug

United statesLarry dillahaNewbridge securities corpMelt pharmaceuticalsSecurities corpHarrow healthMelt pharmaceuticalsHarrow health

Melt Pharmaceuticals Closes $24M in Series B Funding Preferred Stock Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United statesLarry dillahaHarrow incMelt pharmaceuticalsSeriesb preferred stockNorth america

Melt Pharmaceuticals Provides Corporate Update

Melt Pharmaceuticals Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDeb hollidayLarry dillahaCatalent incHolliday communications incPharmaceuticals incDrug administrationHarrow incSafety studyMelt pharmaceuticalsNorth america

Melt Pharmaceuticals MELT-300 (Midazolam 3mg and Ketamine 50mg Sublingual Tablet) Achieves Primary Sedation Endpoint in Phase 2 Pivotal Efficacy and Safety Study

Melt Pharmaceuticals MELT-300 (Midazolam 3mg and Ketamine 50mg Sublingual Tablet) Achieves Primary Sedation Endpoint in Phase 2 Pivotal Efficacy and Safety Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLarry dillahaJohn berdahlDeb hollidayCatalent incHarrow health incDrug administrationPharmaceuticals incHolliday communications incProcedural sedation comparedAll comparator treatment armsIncluding midazolamLess likelyRequire rescue sedation comparedRequire rescue sedation pre operatively comparedMidazolam treatment

Harrow s (HROW) Melt Reports MELT-300 Achieved Primary Sedation Endpoint in Phase 2 Trial

Harrow s (HROW) Melt Reports MELT-300 Achieved Primary Sedation Endpoint in Phase 2 Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLarry dillahaJohn berdahlCatalent incHarrow health incDrug administrationPharmaceuticals incHarrow healthRamsay sedation scaleMelt pharmaceuticals